PKM and cancer: As PKM2 is enriched in most human cancers and is associated with poor clinical outcome [17], it is mostly reported that PKM2 serves as an oncogenic promoter to facilitate cell growth, metastasis, and chemoresistance by either regulating cellular metabolism or targeting different gene expression and signaling pathways as a nuclear transcription cofactor [22,27].